earnings

Lawsuit claims Trump profits unfairly by charging up to $100,000 monthly for exclusive access to presidential posts.

Intellinetics expects double-digit SaaS growth for fiscal 2026 while outlining a 2-4 year shift toward recurring revenue

Biostem raises 2026 revenue outlook to $26M-$29M while targeting manufacturing transfer in H1 2027

OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition

ASX Ltd.’s full-year profit missed estimates and costs grew ahead of incoming chief executive officer Anthony Attia’s arrival at the Australian exchange next month.

Resideo Q2 2026 slides: record results amid major business separation

Cerebras Systems reported better-than-expected second-quarter revenue and raised its full-year guidance.

StubHub Q2 2026 slides: GMS surges 34%, stock falls on outlook

Earnings call transcript: Linamar posts record Q2 2026 sales, shares edge higher

Tokenized assets hit a record and trading activity jumped, but revenue slipped in the firm’s first earnings report since going public.